{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:11:34Z","timestamp":1793221894871,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI20 \/00043"],"award-info":[{"award-number":["ICI20 \/00043"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI23 \/00061"],"award-info":[{"award-number":["FI23 \/00061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eclinm.2026.103874","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:42:59Z","timestamp":1776512579000},"page":"103874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial"],"prefix":"10.1016","volume":"95","author":[{"given":"Cristina","family":"Marcelo-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-6207","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Esteban-Cantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-0545","authenticated-orcid":false,"given":"Roc\u00edo","family":"Montejano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rodr\u00edguez-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Guti\u00e9rrez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-8766","authenticated-orcid":false,"given":"Alejandro","family":"de Gea-Grela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00ednez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-2559","authenticated-orcid":false,"given":"Alejandro D\u00edez","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-3597","authenticated-orcid":false,"given":"Carlos M.","family":"O\u00f1oro-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo Men\u00e9ndez","family":"Colino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed Gonz\u00e1lez","family":"P\u00e9rez de Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Rod\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.103874_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2026.103874_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s41999-018-0148-x","article-title":"Why are people with HIV considered \u201colder adults\u201d in their fifties?","volume":"10","author":"S\u00e1nchez-Conde","year":"2019","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.eclinm.2026.103874_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103896","article-title":"Ageing with HIV: challenges and biomarkers","volume":"77","author":"Rod\u00e9s","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.eclinm.2026.103874_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13148-020-00905-6","article-title":"Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden","volume":"12","author":"Hillary","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.eclinm.2026.103874_bib5","first-page":"9484","article-title":"DNA methylation GrimAge version 2","volume":"14","author":"Lu","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.eclinm.2026.103874_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73420","article-title":"DunedinPACE, a DNA methylation biomarker of the pace of aging","volume":"11","author":"Belsky","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.eclinm.2026.103874_bib7","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2352-3018(21)00006-0","article-title":"Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001\/ANRS143 randomised trial","volume":"8","author":"Esteban-Cantos","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2026.103874_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.eclinm.2026.103874_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pcd.2020.06.001","article-title":"Metformin and risk of cancer among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.eclinm.2026.103874_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13543784.2023.2196010","article-title":"Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease","volume":"32","author":"Dihoum","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.eclinm.2026.103874_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.eclinm.2026.103874_bib12","article-title":"Effect of metformin on the epigenetic age of peripheral blood in patients with diabetes mellitus","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.eclinm.2026.103874_bib13","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","article-title":"Metformin decelerates aging clock in male monkeys","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.eclinm.2026.103874_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103270","article-title":"LILAC pilot study: effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy","volume":"65","author":"Planas","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.eclinm.2026.103874_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13926","article-title":"Cell-type specific impact of metformin on monocyte epigenetic age reversal in virally suppressed older people living with HIV","volume":"23","author":"Corley","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.eclinm.2026.103874_bib16","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2026.103874_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/QAI.0000000000000983","article-title":"The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects","volume":"72","author":"Song","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2026.103874_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc16-1682","article-title":"Growth differentiation factor 15 as a novel biomarker for metformin","volume":"40","author":"Gerstein","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2026.103874_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.eclinm.2026.103874_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.eclinm.2026.103874_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.eclinm.2026.103874_bib22","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.18632\/aging.102173","article-title":"DNA methylation-based estimator of telomere length","volume":"11","author":"Lu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.eclinm.2026.103874_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s43587-022-00248-2","article-title":"A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking","volume":"2","author":"Higgins-Chen","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.eclinm.2026.103874_bib24","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.eclinm.2026.103874_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5770\/cgj.23.463","article-title":"Using the clinical frailty scale in allocating scarce health care resources","volume":"23","author":"Rockwood","year":"2020","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.eclinm.2026.103874_bib26","article-title":"Prognostic value of blood epigenetic biomarkers of aging in persons with well-controlled human immunodeficiency virus (HIV-1) infection","author":"Mart\u00ednez-Mart\u00edn","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2026.103874_bib28","doi-asserted-by":"crossref","first-page":"100695","DOI":"10.1016\/j.lanhl.2025.100695","article-title":"Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial","volume":"6","author":"Witham","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.eclinm.2026.103874_bib29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s40200-021-00869-1","article-title":"The effect of metformin on body mass index and metabolic parameters in non-diabetic HIV-positive patients: a meta-analysis","volume":"20","author":"Harmooshi","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.eclinm.2026.103874_bib30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/QAD.0000000000003947","article-title":"MAVMET trial: maraviroc and\/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV","volume":"38","author":"McCabe","year":"2024","journal-title":"AIDS"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:38:26Z","timestamp":1781671106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S2589537026001215"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103874","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103874"}}